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Background: Fibrin gels are a promising biomaterial for tissue engineering. However, current fabrication methods
are time intensive with inherent variation. There is a pressing need to develop new and consistent approaches
for producing fibrin-based hydrogels for examination.
Findings: We developed a high throughput method for creating fibrin gels using molds fabricated from
polydimethylsiloxane (PDMS). Fibrin gels were produced by adding solutions of fibrinogen and thrombin to
cylindrical defects in a PDMS sheet. Undisturbed gels were collected by removing the sheet, and fibrin gels were
characterized. The characteristics of resulting gels were compared to published data by measuring compressive
stiffness and osteogenic response of entrapped human mesenchymal stem cells (MSCs). Gels exhibited compressive
moduli nearly identical to our previously reported fabrication method. Trends in alkaline phosphatase activity, an
early marker of osteogenic differentiation in MSCs, were also consistent with previous data.
Conclusions: These findings demonstrate a streamlined approach to fibrin gel production that drastically reduces
the time required to make fibrin gels, while also reducing variability between gel batches. This fabrication
technique provides a valuable tool for generating large numbers of gels in a cost-effective manner.
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Background
Fibrin gels are a promising biomaterial, as they can be
delivered in a minimally invasive manner or formed into
an implant and tuned to possess desired characteristics
(e.g., gelation rate, compressive stiffness, degradation rate,
etc.) [1-3]. These biodegradable hydrogels are produced
through the combination of proteins found in the body,
fibrinogen and thrombin, which generates a provisional
matrix that allows cells to encounter an environment that
closely mimics the ECM of a damaged tissue [4,5]. A wide
variety of methods are available to manipulate the physical
properties of these gels, including increasing the protein
concentrations [6], cross linking via enzymes or UV
radiation [7], and adjusting the Ca2+ concentration [8-10].* Correspondence: jkleach@ucdavis.edu
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distribution, and reproduction in any mediumRecently, we showed that supplementing the pre-gel solu-
tion with various concentrations of sodium chloride
(NaCl) alters gel stiffness [11]. This approach addresses
many shortcomings of other fibrin gel fabrication techni-
ques; namely, that one can manipulate gel stiffness using
biomimetic concentrations of fibrinogen and thrombin
while maintaining a slow gelation time, thus limiting stress
on entrapped cells [12].
Previous work in our laboratory fabricated fibrin gels by
combining solutions of fibrinogen and thrombin in
parafilm-covered, cylindrical nylon washers [11]. Once
gelation was complete, the gels were carefully removed
with a metal spatula and placed in tissue culture plates.
This method was taxing to reproduce, required significant
preparation, and was time intensive, requiring more than
12 hours, on average, to produce up to 30 gels. Poly-
dimethylsiloxane (PDMS) is a chemically inert, hydropho-
bic, silicone-based organic polymer that can be produced
with a wide range of viscosities. High viscosity PDMS is
often used in microfluidic devices, and while pliable, it will
retain its form indefinitely. These properties make PDMSentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Gel solution was added to each cylindrical mold, the contents were allowed to gel for 1 hr (1A), then the PDMS sheet was
carefully removed (1B), leaving behind undisturbed fibrin gels (1C).
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inert substrate for use in fabricating fibrin gels [13,14].
This study demonstrates a novel method for producing
fibrin gels using a PDMS mold. Compared to previous
methods, these gels can be fabricated in a high throughput
and cost-effective manner, thus providing an improved
technique for generating reproducible substrates for use
in studies of materials science, cellular biology, and
tissue development.
Methods
Fabrication of PDMS mold
Cylindrical molds were formed using a 6 mm diameter
biopsy punch (Accuderm Inc., Ft. Lauderdale, FL, USA)
pressed into a 2 mm thick sheet of PDMS (Dow Corn-
ing, Midland, MI, USA). The PDMS mold can be used
for up to six months. To initiate gel fabrication, the
PDMS mold was rinsed with distilled water, sterilized by
immersion in 70% ethanol for up to 2 min, and allowed
to dry in an aseptic environment for 5 min. When dry,
the PDMS sheet was placed in a non-treated sterile poly-
styrene dish, creating a seal.Figure 2 Young’s modulus of acellular fibrin gels made in
PDMS molds. Data are mean± SD (n = 9).Fibrin gel preparation
Fibrin gels were prepared by combining 20 mg mL-1
fibrinogen (Calbiochem, Gibbstown, NJ, USA), 1.16-
3.85% (w/v) NaCl (Sigma Aldrich, St. Louis, MO, USA),
2.5 U mL-1 thrombin (Calbiochem), 20 mM CaCl2
(Sigma Aldrich), and 250 KIU mL-1 aprotinin (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA), all in
PBS. A total volume of 80 μL was added to each cylin-
drical mold, and the contents were allowed to gel for
1 hr in standard culture conditions (Figure 1A). The
PDMS sheet was then carefully lifted from the culture
dish (Figure 1B), leaving behind the undisturbed fibrin
gels (Figure 1C), and the gels were transferred to 12-well
tissue culture plates. This fabrication method requires
4 hours to produce up to 100 gels.
Compressive testing of fibrin gels
We measured the compressive moduli of gels made with
varying salt concentrations to verify that fibrin gels fabri-
cated in this manner possessed comparable mechanical
properties to those prepared using previously published
methods. Acellular gels containing increasing NaCl con-
tent were allowed to gel for 1 hr, transferred to PBS and
allowed to swell for 1 hr, and then any excess fluid was
blotted off before analysis. Gels were then loaded be-
tween two flat platens and compressed at 1 mm/min
(Instron 3345 Compressive Testing System, Norwood,
MA, USA). The compressive moduli were measured from















1.16% 9.29 1.78 12.56 1.53 26.01%
2.21% 16.29 0.57 16.64 1.89 2.10%
3.85% 15.78 2.61 17.24 2.85 8.49%
Figure 3 Intracellular ALP activity of MSCs entrapped in fibrin
gels. Data are mean± SD (n = 9). *p< 0.05 vs. other groups.
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We analyzed the osteogenic response of human mesen-
chymal stem cells (MSCs) entrapped within fibrin gels as
a measure of comparison with previously reported fabri-
cation methods. Human MSCs (Lonza, Walkersville,
MD, USA) were expanded in αMEM (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal bovine
serum (JR Scientific, Woodland, CA, USA) and 1%
penicillin/ streptomycin (Mediatech, Manassas, VA,
USA) until use at passage 6. MSCs were added to the
pre-gel solution at 1.5 × 10 [6] cells mL-1 of gel solution
and cultured for various time intervals in the αMEM
media described above.
At days 3, 5, 7, and 10, the gels were collected and soni-
cated in 400 μL passive lysis buffer (Promega, Madison,
WI). Samples were centrifuged at 5000 rpm for 10 min to
pellet the cell debris, and the supernatant was collected.
The supernatant was analyzed for intracellular alkaline
phosphatase (ALP) activity using a p-nitrophenyl phos-
phate (PNPP) colorometric assay as previously described
[11]. DNA content, a measure of cell growth, was assayed
from the supernatant using the Quant-iT PicoGreen
dsDNA Assay Kit (Invitrogen).
Statistical analysis
Results are expressed as mean ± standard deviation (SD).
Statistical analyses were performed by ANOVA followed
by Student–Newman–Keuls post-hoc tests assessing sig-
nificance to probability values (p) <0.05.
Results and discussion
Material characterization
The compressive stiffness of fibrin gels with increasing
NaCl content were determined and compared to previ-
ously reported values. Similar to gels formed in nylon
washers, fibrin gels with increasing NaCl content exhib-
ited increasing Young’s modulus up to 2.21% (w/v)
NaCl, above which the modulus began to decrease, on
average (Figure 2). Experimentally determined values ofgel stiffness were similar to previously reported values of
stiffness for gels produced in the nylon washers (Table 1).
These data demonstrate that this high throughput method
yields fibrin gels with similar mechanical properties to
those produced with the nylon washer technique.
Osteogenic response of entrapped MSCs
We measured ALP activity of MSCs entrapped in the
fibrin gels formed with the addition of 1.16, 2.21, or
3.85% (w/v) NaCl. We observed the expected trend
of temporal protein activity in each group, with ALP
activity peaking on different days as a function of gel
composition. ALP activity followed a similar trend to
previously published values for MSCs suspended in
fibrin gels with similar NaCl concentrations formed
within nylon washers (Figure 3). These data provide an-
other indication that cells behave similarly when
entrapped in fibrin gels formed in either PDMS molds
or nylon washers.
Conclusions
We developed a reproducible, cost-effective, and quick
method for fabricating fibrin gels using molds formed in
PDMS. This new fabrication method generated fibrin
gels with similar compressive moduli and the capacity to
promote osteogenic differentiation of entrapped MSCs.
Values from these two characterization assays were
similar to our previous data, thus validating this new
approach for the consistent and reproducible production
of many hydrogels in a fraction of the time required for
previous methods.
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